Company Encyclopedia
View More
name
MICROPORT
00853.HK
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People’s Republic of China, Europe, Middle East and Africa, Japan, and internationally. The company’s Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma products, and other professional implants and instruments. The company’s Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers.
133.60 B
00853.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care EquipmentIndustry
Industry Ranking22/26
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-24.77%E
    • Profit Margin-16.06%D
    • Gross Margin56.36%B
  • Growth ScoreC
    • Revenue YoY-1.03%D
    • Net Profit YoY60.36%B
    • Total Assets YoY-0.07%C
    • Net Assets YoY-7.80%D
  • Cash ScoreD
    • Cash Flow Margin-622.59%E
    • OCF YoY-1.03%D
  • Operating ScoreD
    • Turnover0.27D
  • Debt ScoreD
    • Gearing Ratio68.71%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Is Shanghai MicroPort MedBot (SEHK:2252)’s Board Revamp Reframing Its Governance Risk‑Reward Profile?

    Shanghai MicroPort MedBot (SEHK:2252) has revamped its board and governance structure, appointing Dr. Zhaohua Chang as chairperson and adding new directors. This overhaul aims to balance growth, risk management, and shareholder interests, potentially influencing the company's investment narrative and oversight framework. Despite ongoing losses, the company is transitioning from R&D to commercialization, with key catalysts being execution and profitability. The governance changes may not directly impact earnings but could affect cost and risk oversight. Shares are rising but may be overvalued by 25%.

    Simplywall·
    HK
    00853
    -0.71%
    Simplywall·
    HK
    00853
    -0.71%

    MicroPort CRM Wins CE Mark Approval for SmartView Connect App Mobile in Europe and Australia

    MicroPort Scientific Corporation has received CE mark approval for its SmartView Connect™ App Mobile under the new Medical Device Regulation, allowing broader deployment in Europe and Australia. This approval supports the expansion of connected cardiac care for patients with Bluetooth-enabled cardiac devices.

    Reuters·
    HK
    00853
    -0.71%
    Reuters·
    HK
    00853
    -0.71%

    MicroPort CardioFlow Corrects Deadline for Share Transfer Ahead of EGM

    MicroPort CardioFlow Medtech Corporation has corrected the deadline for lodging share transfers to qualify for voting at the upcoming EGM. The new deadline is 4:30 p.m. on Tuesday, December 9, 2025, instead of the previously stated December 10, 2025. All other details remain unchanged.

    Reuters·
    HK
    00853
    -0.71%
    Reuters·
    HK
    00853
    -0.71%

    Shanghai MicroPort MedBot Group Co. Ltd. Held Extraordinary General Meeting

    Shanghai MicroPort MedBot Group Co. Ltd. held an extraordinary general meeting on November 25, 2025, where proposals such as the appointment of directors, amendments to articles of association, changes in board committees, and a change in authorised representative were approved.

    Reuters·
    HK
    00853
    -0.71%
    Reuters·
    HK
    00853
    -0.71%

    MicroPort CardioFlow Medtech Corporation Announces Date for Extraordinary General Meeting

    MicroPort CardioFlow Medtech Corporation will hold an extraordinary general meeting on December 15, 2025, in Shanghai, China. Shareholders will vote on the merger agreement between MicroPort CardioFlow CRM Limited and MicroPort Cardiac Rhythm Management Limited. The meeting will address the approval, ratification, and confirmation of the merger and related transactions.

    Reuters·
    HK
    00853
    -0.71%
    Reuters·
    HK
    00853
    -0.71%
    © 2025 Longbridge｜Disclaimer